Statement of Changes in Beneficial Ownership (4)
20 February 2015 - 11:10PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Quinlan Paul T
|
2. Issuer Name
and
Ticker or Trading Symbol
SOLAZYME INC
[
SZYM
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
General Counsel
|
(Last)
(First)
(Middle)
SOLAZYME, INC., 225 GATEWAY BOULEVARD
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/19/2015
|
(Street)
SOUTH SAN FRANCISCO, CA 94080
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (right to buy)
|
$6.79
|
2/19/2015
|
|
D
|
|
|
40000
|
(1)
|
12/15/2020
|
Common Stock
|
40000
|
(2)
|
0
|
D
|
|
Employee Stock Option (right to buy)
|
$2.50
|
2/19/2015
|
|
A
|
|
20000
|
|
(3)
|
12/15/2020
|
Common Stock
|
20000
|
(2)
|
20000
|
D
|
|
Employee Stock Option (right to buy)
|
$8.77
|
2/19/2015
|
|
D
|
|
|
60000
|
(4)
|
3/8/2021
|
Common Stock
|
60000
|
(5)
|
0
|
D
|
|
Employee Stock Option (right to buy)
|
$2.50
|
2/19/2015
|
|
A
|
|
30000
|
|
(3)
|
3/8/2021
|
Common Stock
|
30000
|
(5)
|
30000
|
D
|
|
Employee Stock Option (right to buy)
|
$11.49
|
2/19/2015
|
|
D
|
|
|
100000
|
(6)
|
2/10/2022
|
Common Stock
|
100000
|
(7)
|
0
|
D
|
|
Employee Stock Option (right to buy)
|
$2.50
|
2/19/2015
|
|
A
|
|
50000
|
|
(3)
|
2/10/2022
|
Common Stock
|
50000
|
(7)
|
50000
|
D
|
|
Employee Stock Option (right to buy)
|
$8.35
|
2/19/2015
|
|
D
|
|
|
50000
|
(8)
|
2/24/2023
|
Common Stock
|
50000
|
(9)
|
0
|
D
|
|
Employee Stock Option (right to buy)
|
$2.50
|
2/19/2015
|
|
A
|
|
25001
|
|
(10)
|
2/24/2023
|
Common Stock
|
25001
|
(9)
|
25001
|
D
|
|
Employee Stock Option (right to buy)
|
$11.11
|
2/19/2015
|
|
D
|
|
|
55000
|
(11)
|
2/11/2024
|
Common Stock
|
55000
|
(12)
|
0
|
D
|
|
Employee Stock Option (right to buy)
|
$2.50
|
2/19/2015
|
|
A
|
|
27500
|
|
(13)
|
2/11/2024
|
Common Stock
|
27500
|
(12)
|
27500
|
D
|
|
Explanation of Responses:
|
(
1)
|
The option provided for monthly vesting as to 1/48 of the underlying shares beginning on December 16, 2010.
|
(
2)
|
On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 40,000 shares of SZYM common stock granted to the reporting person on December 16, 2010. In exchange, the reporting person received a replacement option, for 20,000 shares, having an excercise price of $2.58 a share.
|
(
3)
|
The option vests in full on January 1, 2016.
|
(
4)
|
The option provided for monthly vesting as to 1/48 of the underlying shares beginning on March 9, 2011.
|
(
5)
|
On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 shares of SZYM common stock granted to the reporting person on March 9, 2011. In exchange, the reporting person received a replacement option, for 30,000 shares, having an excercise price of $2.58 a share.
|
(
6)
|
The option provided for monthly vesting as to 1/48 of the underlying shares beginning on January 1, 2012.
|
(
7)
|
On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 shares of SZYM common stock granted to the reporting person on February 11, 2012. In exchange, the reporting person received a replacement option, for 50,000 shares, having an excercise price of $2.58 a share.
|
(
8)
|
The option provided for monthly vesting as to 1/48 of the underlying shares beginning on January 1, 2013.
|
(
9)
|
On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 shares of SZYM common stock granted to the reporting person on February 25, 2013. In exchange, the reporting person received a replacement option, for 25,001 shares, having an excercise price of $2.58 a share.
|
(
10)
|
The option vests as to 18,750 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly thereafter.
|
(
11)
|
The option provided for monthly vesting as to 1/48 of the underlying shares beginning on January 1, 2014.
|
(
12)
|
On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 55,000 shares of SZYM common stock granted to the reporting person on February 12, 2014. In exchange, the reporting person received a replacement option, for 27,500 shares, having an excercise price of $2.58 a share.
|
(
13)
|
The option vests as to 13,750 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly thereafter.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Quinlan Paul T
SOLAZYME, INC.
225 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
|
|
|
General Counsel
|
|
Signatures
|
/s/ Paul Quinlan
|
|
2/20/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|